NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Provista Diagnostics has raised $3.9 million, it said in a regulatory document filed on Monday. 

The Scottsdale, Ariz.-based firm did not respond to requests for comment. In a document filed with the US Securities and Exchange Commission, Provista said that there were 24 investors in the private offering of equity. It did not say how the funds would be used. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.